To evaluate the effects of laparoscopic Roux-en-Y gastric bypass (LRYGBP) with and without fundus resection on diabetes remission and metabolic parameters, specifically focusing on primary outcomes like HbA1c levels and secondary outcomes including BMI and glycemic parameters, in patients with obesity and type 2 diabetes mellitus (T2DM).
Key Findings:
LRYGBP+FR may enhance glycemic control through mechanisms involving gut hormones, suggesting a potential metabolic advantage in T2DM management.
No intraoperative complications were reported, indicating the safety of both procedures.
The study suggests a potential metabolic advantage of fundus resection in T2DM management, warranting further investigation.
Interpretation:
The findings indicate that modifying LRYGBP with fundus resection could optimize diabetes management, potentially through altered gut hormone dynamics, which may play a crucial role in improving glycemic control.
Limitations:
Small sample size limits the generalizability of the findings, potentially affecting the robustness of the conclusions.
Short follow-up duration may not capture long-term effects, necessitating further studies to assess sustainability.
Conclusion:
LRYGBP with fundus resection may provide improved metabolic outcomes in T2DM patients, warranting further investigation in larger cohorts to validate these findings.
These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.
